Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Nicholas J Chevalier

3PUBLICATIONS
77CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Jan 08, 2026
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.

Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel

|Nov 02, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.

Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin

Pageof 1

Frequent Collaborators

3 joint publications

Andreas Varkaris

3 joint publications

Dejan Juric

3 joint publications

Allison M Kehlmann

2 joint publications

Ferran Fece de la Cruz

2 joint publications

Bryanna L Norden

2 joint publications

Kayao Lau

2 joint publications

Haley Barnes

2 joint publications

Sara Ehnstrom

2 joint publications

Anastasia-Maria Stavridi

2 joint publications

Janice S Kim

Frequent Collaborators

3 joint publications

Andreas Varkaris

3 joint publications

Dejan Juric

3 joint publications

Allison M Kehlmann

2 joint publications

Ferran Fece de la Cruz